Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary
The aim of this work is to compare the clinical outcomes of letrozole with laparoscopic ovarian drilling (LOD) in patients with clomiphene-citrate-resistant polycystic ovary syndrome (PCOS).
Induction of Ovulation
DRUG: group A 2.5 mg letrozole oral tablets|PROCEDURE: laparoscopic ovarian drilling
OVULATION RATE, SERUM PROGESTERON LEVEL, 7 DAYS BEFORE NEXT MENSES
BIOCHEMICAL PREGNANCY RATE, BY SERUM HCG, AFTER 30 DAYS OF INTERVENTION|CLINICAL PREGNANCY RATE, BY FETAL HEART RATE MONITORING BY ULTRASOUND SCAN, AT 6 WEEKS GESTATION
The aim of this work is to compare the clinical outcomes of letrozole with laparoscopic ovarian drilling (LOD) in patients with clomiphene-citrate-resistant polycystic ovary syndrome (PCOS).